Each month, the Biosimilars Council sends a newsletter with the latest updates in the biosimilars industry, including policy movement, educational resources and upcoming events. To stay current on biosimilars, sign up to receive these monthly updates on the form to the right.
A Note from Biosimilars Council Executive Director Christine Simmon
This month, the Biden administration again referred to biosimilars by name in a White House fact sheet on increasing access and lowering the price of prescription medicines. While much remains to be seen about the specifics of Congress and the Administration’s work on this issue, we are encouraged by the Administration’s stated goal of “accelerating the development and uptake of generic and biosimilar drugs that give patients the same exact clinical benefit but at a fraction of the price.” Over the next weeks and months, we will continue to pursue and create opportunities to elevate biosimilars and the value they provide across our health care system.
On that note, I am pleased to announce that AAM and the Biosimilars Council will be hosting our annual GRx+Biosims 2021 conference November 8-10. I invite you to join us to discuss the future of biosimilar medicines in the United States. This year’s event will be held virtually. Information and registration are available here. To learn about sponsorship opportunities, please contact us through this form.